Stock analysts at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a report released on Monday. The firm set a “hold” rating on the stock.
China Pharma Trading Down 4.4 %
NYSE CPHI opened at $0.25 on Monday. China Pharma has a 12 month low of $0.24 and a 12 month high of $2.05. The stock has a 50-day simple moving average of $0.29 and a 200 day simple moving average of $0.39. The company has a current ratio of 0.89, a quick ratio of 0.25 and a debt-to-equity ratio of 0.17.
China Pharma (NYSE:CPHI – Get Free Report) last announced its quarterly earnings results on Wednesday, May 15th. The company reported ($0.07) earnings per share (EPS) for the quarter. China Pharma had a negative return on equity of 54.31% and a negative net margin of 55.42%. The business had revenue of $1.37 million during the quarter.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Articles
- Five stocks we like better than China Pharma
- What is the Australian Securities Exchange (ASX)
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- Dividend Payout Ratio Calculator
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- What is a Special Dividend?
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
